CDC Responds to Ebola Outbreak in Democratic Republic of the Congo and Uganda

The Centers for Disease Control and Prevention (CDC) has mobilized an international response following the identification of an Ebola outbreak affecting the Democratic Republic of the Congo (DRC) and Uganda. As of May 18, 2026, health officials are working around the clock to contain the spread of the virus and manage the care of affected individuals.

CAPT Satish Pillai, MD, MPH, Incident Manager for the CDC’s Ebola Response, confirmed that one American working in the DRC has tested positive for the Ebola virus. The individual, who developed symptoms over the weekend, was confirmed positive late Sunday. The CDC is coordinating with the Department of State to facilitate the transfer of this patient and several other high-risk contacts to Germany for specialized care and monitoring.

Public Health Measures and Travel Protocols

In response to the evolving situation, the CDC, in conjunction with the Department of Homeland Security and other federal partners, has implemented proactive measures to prevent the virus from entering the United States. Key actions include:

• Enhanced Screening: The CDC is increasing public health screening and traveler monitoring for individuals arriving from the DRC, Uganda, and South Sudan.
• Entry Restrictions: New restrictions apply to non-U.S. Passport holders who have been present in Uganda, the DRC, or South Sudan within the previous 21 days.
• Coordination: The agency is working closely with airlines, international partners, and port-of-entry officials to identify and manage potentially exposed travelers.
• Operational Support: The CDC has activated its Emergency Operations Center and is deploying additional technical experts from its headquarters in Atlanta to support surveillance, contact tracing, and laboratory testing in the affected regions.

Understanding the Current Outbreak

This event marks the 17th recorded Ebola outbreak in the DRC. Dr. Pillai noted that the current outbreak involves the Bundibugyo species of the virus, a rare strain with only two previous documented outbreaks: one in Uganda in 2007 and one in the DRC in 2015.

Regarding medical countermeasures, Dr. Pillai clarified that there are currently no approved therapeutics or prophylactic measures specifically for the Bundibugyo strain. However, the CDC is collaborating with interagency partners to ensure that available supportive care and experimental protocols are accessible for those in need.

Key Takeaways for the Public

• Risk Assessment: The CDC emphasizes that the risk of Ebola to the general public in the United States remains low.
• Travel Guidance: Travelers to the region are advised to avoid contact with sick individuals, report any symptoms immediately, and consult the latest CDC travel health notices.
• Ongoing Response: The CDC continues to work with ministries of health in the DRC and Uganda to strengthen laboratory diagnostic capacity and infection prevention efforts.

Looking Ahead

The situation remains highly fluid as the CDC continues to gather data and adjust its response strategy. The agency is prioritizing the security of Americans both abroad and domestically while providing robust technical support to international partners on the ground. Further updates will be provided as more information becomes available through official CDC channels.

Disclaimer: This report is based on information provided by the Centers for Disease Control and Prevention as of May 18, 2026. For the most current travel notices and health guidance, please visit the official CDC website.